Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors

Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling and destruction that leads to severe disability. There are no clear guidelines regarding the order of therapies. Gathering data on treatment patterns outside of a clinical trial setting can provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xue, Lobo, Francis, Broder, Michael S., Chang, Eunice, Gibbs, Sarah N., Ridley, David J., Yermilov, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2021
Materias:
Autoimmune Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133796/
https://www.ncbi.nlm.nih.gov/pubmed/34046511
http://dx.doi.org/10.36469/jheor.2021.23684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133796/
https://www.ncbi.nlm.nih.gov/pubmed/34046511
http://dx.doi.org/10.36469/jheor.2021.23684

Ejemplares similares